← FDA Drug Approvals (Drugs@FDA)

CAMBIA

NDA · New Drug Application · Sponsor: ASSERTIO SPECLTY · Approved 2009-06-17

Drug application

FDA Application #

NDA022165

Application type

New Drug Application

Brand name

CAMBIA

Generic name

DICLOFENAC POTASSIUM

Active ingredients

DICLOFENAC POTASSIUM

Dosage form

FOR SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

ASSERTIO SPECLTY

Manufacturer

Leading Pharma, LLC

First approval

2009-06-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown